Roche, a pharmaceutical and diagnostics company, has acquired Stratos Genomics for their Sequencing by Expansion technology.
“We are thrilled to join the Roche family, which will allow us to combine our unique Sequencing by Expansion chemistry with the Roche nanopore sequencer. With our combined expertise and complementary technologies, we are well-positioned to open the path to deliver scalable, high-performance sequencing to clinicians and researchers.”
Mark Kokoris, President & CEO at Stratos Genomics
The Roche nanopore sequencer will allow for fast and cost-effective diagnostic testing using DNA sequencing.